Mani Mohindru, CFO & Chief Strategy Officer at Cara Therapeutics, Inc. (CARA), sold 37,431 shares at $25.00 ($936K) on 2019-07-15, disclosed to the SEC on 2019-07-17.
Open-market sale of $936k CARA by CFO & Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| CARA | SELL | 2019-12-04 | $162K | — | Filing → |
| CARA | SELL | 2019-05-30 | $107K | — | Filing → |
| CARA | SELL | 2019-03-15 | $613K | — | Filing → |